Literature DB >> 26451745

Blood-induced arthropathy in hemophilia: mechanisms and heterogeneity.

Carl P Blobel1, Coline Haxaire1, George D Kalliolias1, Edward DiCarlo2, Jane Salmon3, Alok Srivastava4.   

Abstract

Hemophilia A is an X-linked bleeding disorder that can be largely controlled by treatment with recombinant factor VIII. However, this treatment is only partially effective in preventing hemophilic arthropathy (HA), a debilitating degenerative joint disease that is caused by intra-articular bleeding events. The disease progression of HA has several distinct steps, beginning with hemophilic synovitis (HS), a hyperplasia of the synovial lining coupled with a neovascular response, followed by joint erosion with cartilage destruction and erosion of the underlying bone. The early stages of HA have certain features in common with arthritides such as rheumatoid arthritis (RA), whereas the later degenerative stages of HA have some similarities with osteoarthritis (OA). The main purpose of this review is to explore the similarities between HA with RA and OA and discuss how this information could potentially help understand the pathogenesis of HA and uncover new treatment opportunities. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2015        PMID: 26451745     DOI: 10.1055/s-0035-1564445

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  10 in total

1.  Joint scores in hemophilic arthropathy in children: Developing country perspectives.

Authors:  Aritra Guha; Akash Rai; Arnab Nandy; Tanushree Mondal; Narayan Pandit; Sumantra Guha; Dipankar Gupta; Rakesh Mondal
Journal:  Eur J Rheumatol       Date:  2019-12-16

2.  Borrowing (once again) from the animal kingdom.

Authors:  Leonardo Pasalic; Emmanuel J Favaloro
Journal:  Blood Transfus       Date:  2016-07-25       Impact factor: 3.443

3.  Selective inhibition of activated protein C anticoagulant activity protects against hemophilic arthropathy in mice.

Authors:  Jhansi Magisetty; Vijay Kondreddy; Shiva Keshava; Kaushik Das; Charles T Esmon; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2022-05-05       Impact factor: 25.476

4.  EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.

Authors:  Jhansi Magisetty; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

5.  Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway.

Authors:  Coline Haxaire; Narine Hakobyan; Tania Pannellini; Camila Carballo; David McIlwain; Tak W Mak; Scott Rodeo; Suchitra Acharya; Daniel Li; Jackie Szymonifka; Xiangqian Song; Sébastien Monette; Alok Srivastava; Jane E Salmon; Carl P Blobel
Journal:  Blood       Date:  2018-05-18       Impact factor: 22.113

Review 6.  Ultrasound for Early Detection of Joint Disease in Patients with Hemophilic Arthropathy.

Authors:  Matteo Nicola Dario Di Minno; Gianluigi Pasta; Sonia Airaldi; Federico Zaottini; Antonio Storino; Ernesto Cimino; Carlo Martinoli
Journal:  J Clin Med       Date:  2017-07-31       Impact factor: 4.241

7.  Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres.

Authors:  Matteo Nicola Dario Di Minno; Mariasanta Napolitano; Anna Chiara Giuffrida; Erminia Baldacci; Christian Carulli; Elena Boccalandro; Clarissa Bruno; Eleonora Forneris; Irene Ricca; Walter Passeri; Marco Martinelli; Gianna Franca Rivolta; Luigi Piero Solimeno; Carlo Martinoli; Angiola Rocino; Gianluigi Pasta
Journal:  Br J Haematol       Date:  2021-12-19       Impact factor: 8.615

8.  Simultaneous bilateral total knee arthroplasty in patients with end-stage hemophilic arthropathy: a mean follow-up of 6 years.

Authors:  Chao Jiang; Yan Zhao; Bin Feng; Jiliang Zhai; Yanyan Bian; Guixing Qiu; Xisheng Weng
Journal:  Sci Rep       Date:  2018-01-25       Impact factor: 4.379

9.  Health-Related Quality of Life and Association With Arthropathy in Greek Patients with Hemophilia.

Authors:  Agoritsa Varaklioti; Nick Kontodimopoulos; Dimitris Niakas; Anna Kouramba; Olga Katsarou
Journal:  Clin Appl Thromb Hemost       Date:  2017-10-09       Impact factor: 2.389

10.  Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast-like synoviocytes.

Authors:  Sandra Mignot; Nicolas Cagnard; Benoit Albaud; Cécile Bally; Justine Siavellis; Olivier Hermine; Laurent Frenzel
Journal:  J Cell Mol Med       Date:  2020-11-07       Impact factor: 5.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.